The Center of Gastrointestinal and Minimally Invasive Surgery, Department of General Surgery, The Third People's Hospital of Chengdu/The Affiliated Hospital of Southwest Jiaotong University, Chengdu, People's Republic of China.
Public Health Nutr. 2024 Sep 24;27(1):e168. doi: 10.1017/S1368980024001502.
To assess the relationship between dietary intake of -carotene, -carotene, -cryptoxanthin, lycopene and lutein+zeaxanthin (LZ) and occurrence of metabolic dysfunction-associated fatty liver disease (MAFLD).
Cross-sectional study design. The MAFLD diagnosis was based on hepatic steatosis and metabolic dysregulation. Carotenoid intake was adjusted for using an energy-adjusted model. Logistic regression and restricted cubic spline (RCS) analyses were used to assess the relationships, with sensitivity analysis to validate the findings. Weighted quantile sum regression (WQS) was used to explore the combined effect of these carotenoids on MAFLD. Subgroup analyses were conducted to identify population-specific associations.
National Health and Nutrition Examination Survey (NHANES) 2017-March 2020.
This study included 5098 individuals aged 18 years and older.
After adjusting for potential confounders, a weak inverse association was observed between -carotene and -carotene intakes and MAFLD occurrence (all value <0·05). The highest quartile of -carotene intake showed a significantly lower occurrence of MAFLD compared with the lowest quartile (OR = 0·65; 95 % CI: 0·44, 0·97). RCS analysis showed that a significantly lower occurrence of MAFLD was associated with a higher intake of the four carotenoids, excluding lycopene. Furthermore, the WQS analysis revealed a negative relationship between combined carotenoid intake and MAFLD occurrence (OR = 0·95, 95 % CI: 0·90, 1·00, = 0·037). Subgroup analyses showed dietary carotenoid intake was associated with reduced MAFLD occurrence in populations aged 50-69 years, females, physically active individuals and non-drinkers.
Higher dietary intake of carotenoids is associated with lower MAFLD occurrence. However, this relationship varies among individuals of different ages, sexes and lifestyles.
评估 β-胡萝卜素、β-隐黄质、番茄红素、叶黄素和玉米黄质(LZ)的饮食摄入量与代谢相关脂肪性肝病(MAFLD)发生之间的关系。
横断面研究设计。MAFLD 的诊断基于肝脂肪变性和代谢失调。使用能量调整模型调整类胡萝卜素的摄入量。使用逻辑回归和限制立方样条(RCS)分析评估这些关系,并进行敏感性分析验证结果。加权分位数总和回归(WQS)用于探索这些类胡萝卜素对 MAFLD 的综合影响。进行亚组分析以确定特定人群的关联。
美国国家健康和营养调查(NHANES)2017 年 3 月至 2020 年。
本研究纳入了 5098 名年龄在 18 岁及以上的个体。
在调整了潜在混杂因素后,β-胡萝卜素和β-隐黄质的摄入量与 MAFLD 的发生呈弱负相关(所有 P 值<0.05)。与最低四分位相比,β-胡萝卜素摄入量最高的四分位数 MAFLD 的发生明显较低(OR=0.65;95%CI:0.44,0.97)。RCS 分析显示,除了番茄红素外,较高的四种类胡萝卜素摄入量与 MAFLD 的发生呈显著负相关。此外,WQS 分析显示,组合类胡萝卜素的摄入量与 MAFLD 的发生呈负相关(OR=0.95,95%CI:0.90,1.00, P=0.037)。亚组分析显示,在 50-69 岁、女性、有体力活动的个体和不饮酒的人群中,膳食类胡萝卜素的摄入量与 MAFLD 的发生减少有关。
较高的饮食类胡萝卜素摄入量与较低的 MAFLD 发生有关。然而,这种关系在不同年龄、性别和生活方式的个体中有所不同。